From Copying to Improving: The Power of CRISPR in Animal Genetics

When we think of biotechnology, cloning often comes to mind—the creation of a genetic twin through Somatic Cell Nuclear Transfer (SCNT). While cloning marked a milestone by proving that replication of complex mammals is possible, its impact remains limited by inefficiency, high costs, and ethical concerns. Today, the frontier of genetic science is shifting. The rise of CRISPR-Cas9 offers not only replication, but precise enhancement, ushering in a future where life can be improved rather than merely copied.

Cloning revealed the possibilities of genetic manipulation, but also its constraints. SCNT typically yields success rates of less than 10 percent, with high mortality rates and health risks for surrogate animals. Moreover, cloning reproduces the genome exactly as it is—strengths and weaknesses alike. For conservation or agriculture, replication alone cannot address inherited vulnerabilities or environmental challenges.

Cloning showed us that genetic identity could be preserved, but it did not provide the tools to evolve that identity. That is where CRISPR steps in.

CRISPR-Cas9 is transforming biotechnology by allowing scientists to edit DNA sequences with unprecedented accuracy. Unlike cloning, which creates identical genetic copies, CRISPR enables targeted modification—correcting harmful mutations, removing undesirable traits, or even adding new beneficial characteristics.

Potential applications are wide-ranging:

Where cloning looked backward—toward replicating what already exists—CRISPR looks forward, creating organisms adapted for future challenges.

CRISPR is not limited to agriculture or companion animals. It has significant implications for conservation biology. Endangered species often suffer from reduced genetic diversity, making them vulnerable to disease and environmental change. Through CRISPR, scientists may be able to reintroduce lost genetic variation, bolster resilience, or even restore extinct traits critical for survival.

In combination with biobanking, which preserves genetic material in cryogenic storage, CRISPR creates the possibility of both safeguarding species and actively improving their chances of survival. For example, frozen genetic samples from threatened fish or mammals could be edited to remove harmful mutations before being reintroduced through breeding programs.

The ability to edit life raises profound ethical questions. Cloning sparked debate over identity and animal welfare; CRISPR extends that debate into new territory. Concerns include unintended genetic side effects, ecological risks if edited organisms are released, and broader questions about how far humans should go in reshaping nature.

These challenges call for rigorous oversight, transparent governance, and international collaboration. Genetic innovation must be guided by ethical frameworks that balance the promise of CRISPR with respect for ecological integrity and animal welfare.

The future of animal genetics may not lie in cloning or CRISPR alone, but in their integration. Cloning provides a platform for replication, biobanking secures the raw genetic material, and CRISPR allows for improvement. Together, these tools could redefine what is possible in medicine, agriculture, and biodiversity preservation.

At Skytyx Biobank, we view CRISPR not as science fiction, but as a practical tool already reshaping the boundaries of biotechnology. By combining it with long-term genetic preservation and cloning, we aim to advance both the protection and the improvement of life.

The history of biotechnology shows a clear progression. Cloning was about proving replication; biobanking was about preserving potential; CRISPR is about harnessing that potential for transformation.

The future of genetics will not be defined by duplication alone, but by innovation that enhances resilience, health, and sustainability. In moving from copying to improving, CRISPR offers the tools to reimagine not just the future of animals—but the future of life itself.